FDA Investigating Link Between Popular Diabetes Drugs and Pancreatic Cancer

The popular diabetes drugs Januvia and Byetta, which were previously connected to an increased risk of pancreatitis, are now under investigation by the FDA to determine if they are associated with pancreatic cancer.

The FDA said that researchers have found precancerous changes on the cellular level in pancreatic tissue specimens from deceased users of Januvia and Byetta.

The FDA is encouraging users of the drugs to continue taking them as directed by their healthcare providers, but they are encouraging users and physicians to be alert to adverse events and report them to the FDA MedWatch program.

To learn more, click here.